JUN 12, 2017 5:41 PM PDT

Designer Molecule can Stop the Flu

WRITTEN BY: Carmen Leitch

Scientists are taking a new approach in the fight against the flu. They have engineered a protein that acts to stop the virus from infecting cells, and while a lot more research is yet to be done, the new protein has been promising in tests done with cells in culture and animal models. The work, outlined in the video below, has been published in Nature Biotechnology.

Influenza is a public health threat, causing serious illness in anywhere from three to five million people in one year, an infection that is deadly to some 250,000 to 500,000 people, usually those with weak immune systems. 

Vaccines are one way people can help prevent flu infection, but they are not effective against all strains and they sometimes don’t trigger enough of a response in some recipients. Drugs that act to fight the flu have traditionally been directed at proteins in the viral coat. Neuraminidase is one, but viruses have already started to build resistance to neuraminidase drugs. Another target on scientists’ radar is hemagglutinin (HA). 

HA, a protein shaped like a mushroom, functions to aid the cell infection process. It begins by attaching its cap to three sugar molecules on the targeted cell individually. After binding, HA uses its stem like a hook to pull the virus close to the cell, after which it fuses and ejects the viral load into the cell.

A designer protein (brown and orange) fits snugly on top of the influenza virus's hemagglutinin protein (green), which helps the virus latch onto and infect cells. / Credit: Eva-Maria Strauch

David Baker, a computational biologist at the University of Washington in Seattle, led researchers in 2011 who synthesized a protein that binds to the stem portion of HA and could halt viral infection in cell culture models. The stem is often shielded by protein that puts it out the reach of drugs, however.

Baker’s team has now engineered proteins that target the exposed cap of HA instead.

The investigators tested copies of the protein that had been team immobilized nitrocellulose, a membrane that is like a kind of paper. After exposing it to various viral strains, it showed that it could attach to the virus without releasing it. “We call it flu glue, because it doesn’t let go,” Baker explained.

After trying out the protein in culture, the protein could prevent infection in the cells. It also stopped illness in mice when provided one day before or after exposure to virus.

The scientists note that this new protein is unlikely to become a medicine. One issue, explained Baker, is that the protein will not attach to flu strains that tend to sicken people. As such, any future drug be made up of a cocktail of proteins that attach to the HA cap or ones which act together with proteins that bind to the stem. Additionally, designer proteins have to be properly evaluated for safety, Crowe said; they are quite different from natural antibodies that halt HA. “The further you get away from a natural antibody, the less you can predict what will happen,” Crowe said.

This designer protein could one day be used in cheap diagnostic tests for the flu, like a pregnancy test, Baker said. It could also help doctors select the best medicine for flu treatment.

 

Sources: Science, Nature Biotechnology

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
MAR 09, 2021
Immunology
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
MAR 09, 2021
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
Researchers have developed a CRISPR treatment that could potentially treat both viruses that cause COVID-19 and influenz ...
MAR 08, 2021
Microbiology
Researchers Discover a New Symbiosis
MAR 08, 2021
Researchers Discover a New Symbiosis
A new type of endosymbiosis has been discovered; the organisms are shown in this image by S. Ahmerkamp, Max Planck Insti ...
MAR 08, 2021
Genetics & Genomics
A Slowdown in Cells' Protein Construction Drives Huntington's
MAR 08, 2021
A Slowdown in Cells' Protein Construction Drives Huntington's
Huntington's disease begins with symptoms like movement and balance problems, weakness, and behavioral disturbances, and ...
MAR 18, 2021
Drug Discovery & Development
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
MAR 18, 2021
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to ta ...
MAR 21, 2021
Genetics & Genomics
Deciphering How Some Environmental Influences Affect Development
MAR 21, 2021
Deciphering How Some Environmental Influences Affect Development
We know that there are certain substances that can harm a developing fetus, like alcohol or lead. Some health conditions ...
APR 05, 2021
Genetics & Genomics
Understanding Why Redheads Perceive Pain Differently
APR 05, 2021
Understanding Why Redheads Perceive Pain Differently
People with red hair, as well as some animals that have red fur, carry one variation of a gene called melanocortin 1 rec ...
Loading Comments...